EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial

Xiehe Kong iD, Rong Han iD, Xiaopeng Fan, Kai Wei iD, Zhao Ma iD, Guang Yang iD, Yue Zhao iD, Yanting Yang iD, Yun Yang, Jue Hong, Jie Liu, Dan Zhang iD und 1 weitere

Journal of Alzheimer’s Disease · 2026-05 · 111 (2) · 757-767

DOI: 10.1177/13872877261435880 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 30.03.2026. Verfasst von Xiehe Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Acupuncture Therapy, Cholinesterase Inhibitors. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preclinical studies suggest acupuncture may offer symptomatic relief or modify disease progression in Alzheimer's disease (AD), yet clinical evidence remains limited.

Objective

This study evaluated whether adding acupuncture to cholinesterase inhibitors improves outcomes in patients with mild AD and whether any benefits persist after treatment ends.

Methods

In this randomized, single-blind trial, participants with mild AD received either active or sham acupuncture three times per week for 14 weeks in addition to ongoing donepezil therapy, followed by a 14-week washout phase during which acupuncture was discontinued while donepezil was maintained. The primary outcome was change in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog12) from baseline.

Results

A total of 160 participants were enrolled, and 157 were included in the primary analysis (78 active, 79 sham). At week 14, the mean change in ADAS-cog12 was −1.20 for the active acupuncture group versus 0.36 for the sham acupuncture group, yielding a difference of −1.50 (p < 0.001). After washout, no significant difference remained (difference, −0.31; p = 0.54). Adverse events occurred in 37.2% of the active and 45.6% of the sham group. Donepezil-related adverse events were less frequent with active acupuncture (6.4% versus 16.5%; p < 0.05).

Conclusions

Acupuncture, when added to donepezil, improved cognition during active treatment and was associated with fewer cholinergic side effects in patients with mild AD. The cognitive benefits did not persist after acupuncture was discontinued, suggesting that acupuncture serves as an adjunctive symptomatic therapy rather than a disease-modifying intervention.

Trial registration

ClinicalTrials.gov [NCT05078944].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAcupuncture TherapyCholinesterase InhibitorsHumansFemaleMaleSingle-Blind MethodAgedDonepezilTreatment OutcomeAged, 80 and overCombined Modality TherapyIndansPiperidinesNeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer's diseaseacupuncturecholinesterase inhibitorclinical trialdementiadonepezil

Substanzen

DonepezilCholinesterase InhibitorsIndansPiperidines

Autor:innen und Institutionen

  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shanghai Qigong Research Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shanghai Institute of Traditional Chinese Medicine for Mental Health, Shanghai, China.
  • Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Xiehe Kong, Rong Han, Kai Wei, Zhao Ma, Guang Yang, Yue Zhao, Yanting Yang, Dan Zhang, Xiaopeng Ma

Förderung

  • Shanghai Municipal Health Commission

Zitieren

APA

Kong, X., Han, R., Fan, X., Wei, K., Ma, Z., Yang, G., Zhao, Y., Yang, Y., Yang, Y., Hong, J., Liu, J., Zhang, D., & Ma, X. (2026). Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial. Journal of Alzheimer’s Disease, 111(2), 757-767. https://doi.org/10.1177/13872877261435880

Vancouver

Kong X, Han R, Fan X, Wei K, Ma Z, Yang G, et al. Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial. Journal of Alzheimer’s Disease. 2026;111(2):757-767. doi:10.1177/13872877261435880

BibTeX
@article{Kong2026,
  author = {Kong, Xiehe and Han, Rong and Fan, Xiaopeng and Wei, Kai and Ma, Zhao and Yang, Guang and Zhao, Yue and Yang, Yanting and Yang, Yun and Hong, Jue and Liu, Jie and Zhang, Dan and Ma, Xiaopeng},
  title = {Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {111},
  number = {2},
  pages = {757--767},
  doi = {10.1177/13872877261435880}
}
Kostenlos starten →